Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae.
Adult
Animals
Antibodies, Viral
/ blood
Cervix Uteri
/ immunology
Cytokines
/ immunology
Female
HIV Infections
/ immunology
HIV-1
Humans
Immunoglobulin G
/ blood
Macaca fascicularis
Male
Middle Aged
Mucous Membrane
/ immunology
Semen
/ immunology
Uterus
/ immunology
Vaccinia virus
Vagina
/ immunology
Viral Vaccines
HIV-1
female reproductive tract (FRT)
mucosa
seminal plasma
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
11
2018
accepted:
18
02
2019
entrez:
28
3
2019
pubmed:
28
3
2019
medline:
25
8
2020
Statut:
epublish
Résumé
HIV-1 sexual transmission occurs mainly via mucosal semen exposures. In the female reproductive tract (FRT), seminal plasma (SP) induces physiological modifications, including inflammation. An effective HIV-1 vaccine should elicit mucosal immunity, however, modifications of vaccine responses by the local environment remain to be characterized. Using a modified vaccinia virus Ankara (MVA) as a vaccine model, we characterized the impact of HIV-1
Identifiants
pubmed: 30915079
doi: 10.3389/fimmu.2019.00430
pmc: PMC6423065
doi:
Substances chimiques
Antibodies, Viral
0
Cytokines
0
Immunoglobulin G
0
Viral Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
430Références
J Clin Invest. 2002 Jan;109(2):205-11
pubmed: 11805132
Clin Microbiol Infect. 1997 Feb;3(1):19-23
pubmed: 11864071
Int J Mol Med. 2002 Aug;10(2):221-5
pubmed: 12119563
J Virol. 2002 Oct;76(19):9868-76
pubmed: 12208964
Am J Reprod Immunol. 1992 Sep;28(2):85-9
pubmed: 1285856
J Biol Chem. 2004 May 28;279(22):23357-63
pubmed: 15039444
Immunology. 2004 Jun;112(2):290-300
pubmed: 15147572
Reproduction. 2004 Aug;128(2):237-47
pubmed: 15280563
J Androl. 2005 Jul-Aug;26(4):459-69
pubmed: 15955884
Biol Reprod. 2005 Dec;73(6):1253-63
pubmed: 16093359
J Infect Dis. 2006 Oct 1;194(7):912-6
pubmed: 16960778
Mol Hum Reprod. 2007 Jul;13(7):491-501
pubmed: 17483528
Blood. 2008 Mar 1;111(5):2733-43
pubmed: 18156495
Biol Reprod. 2009 May;80(5):1036-45
pubmed: 19164169
AIDS. 2010 Jan 16;24(2):163-87
pubmed: 20010071
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4287-92
pubmed: 20142498
J Infect Dis. 2010 Aug 15;202(3):337-44
pubmed: 20569157
Retrovirology. 2010 Jun 23;7:55
pubmed: 20573198
J Immunol. 2010 Dec 1;185(11):7085-96
pubmed: 20974989
Antiviral Res. 2010 Dec;88 Suppl 1:S3-9
pubmed: 21109065
Am J Reprod Immunol. 2011 Jul;66 Suppl 1:11-22
pubmed: 21726334
AIDS. 2012 Jan 2;26(1):27-36
pubmed: 22095191
J Immunol. 2012 Mar 1;188(5):2445-54
pubmed: 22271649
J Immunol. 2012 Jul 15;189(2):1024-35
pubmed: 22706080
Am J Reprod Immunol. 2012 Dec;68(6):515-21
pubmed: 23006048
Hum Reprod. 2013 Jan;28(1):199-209
pubmed: 23024119
Biol Reprod. 2013 Jan 17;88(1):13
pubmed: 23153564
Cytometry A. 2013 Feb;83(2):182-4
pubmed: 23184609
Nat Rev Immunol. 2013 Apr;13(4):227-42
pubmed: 23470321
Trends Microbiol. 2013 May;21(5):245-52
pubmed: 23489987
Hum Reprod. 2014 Jun;29(6):1255-70
pubmed: 24626806
Am J Reprod Immunol. 2014 Jun;71(6):564-74
pubmed: 24702729
J Vasc Res. 2014;51(3):231-8
pubmed: 25116857
Cell Cycle. 2014;13(24):3878-91
pubmed: 25558831
J Reprod Immunol. 2015 Aug;110:109-16
pubmed: 25799173
Hum Reprod Update. 2016 Apr;22(3):342-57
pubmed: 26884470
AIDS. 2017 Jan 28;31(3):333-342
pubmed: 27835615
J Immunol. 2017 Sep 1;199(5):1923-1932
pubmed: 28760882
Fertil Steril. 1985 Mar;43(3):417-21
pubmed: 3979580
Nat Med. 1996 Oct;2(10):1084-9
pubmed: 8837605
J Reprod Fertil. 1996 Jul;107(2):265-77
pubmed: 8882294
Hum Reprod. 1998 Dec;13(12):3319-25
pubmed: 9886507